# A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity

> **NCT07725809** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 57 (estimated)

## Conditions studied

- Overweight
- Obesity
- Healthy

## Interventions

- **DRUG:** PF-08653945

## Key facts

- **NCT ID:** NCT07725809
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-23
- **Primary completion:** 2027-01-13
- **Final completion:** 2027-01-13
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2026-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725809, "A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07725809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*